Technology: CAR-T, Cell-based gene therapy
Industry: Public
Headquarters: Tübingen, Baden-Wurttemberg, Germany
Founded Date: 2000-01-01
Employees Number: 51-100
Funding Status: IPO
Investors Number: 31
Total Funding: 556233156
Estimated Revenue: $10M to $50M
Last Funding Date: 2022-10-10
Last Funding Type: Post-IPO Equity

Visit Website
info@immatics.com
http://twitter.com/immatics
Register and Claim Ownership